A randomized prospective comparative study on sinonasal morbidity and quality of life of transsphenoidal endoscopic surgery for pituitary adenomas : endonasal versus trans-septal approach

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature..

PURPOSE: Endoscopic endonasal transsphenoidal approach (Endonasal approach) is commonly used to treat pituitary adenomas. The extent of dissection possibly changes the anatomy and the physiology of the nasal cavities and could give rise to post-operative morbidity and the quality of life (QoL). The purpose of this study was to investigate sinonasal morbidity and general QoL in patients who underwent surgery for treatment of pituitary adenoma, comparing Endonasal and endoscopic trans-septal transsphenoidal approach (Trans-septal approach).

METHODS: A prospective observational study, recruiting 40 patients undergoing surgery for pituitary adenoma, 20 via Endonasal approach and 20 via Trans-septal approach at our institution. Surveys with Sinonasal Outcome Test-22 (SNOT-22), Chronic Sinusitis Survey (CSS), and Short Form Health Survey 36 version 2 (SF-36v2) were obtained to collect QoL data pre- and postoperatively.

RESULTS: All the 40 patients completed the questionnaires. At 6 months postoperatively, the SNOT-22 and CSS score shows significant improvements both in Endonasal approach (p = 0.01) and in Trans-septal approach (p = 0.02). No significant difference in sinonasal morbidity is observed between the two groups for SNOT-22 (p = 0.13) and CSS scores, except for sinus headache (p = 0.49), with a better score in Endonasal approach. The mean SF-36v2 scores remain the same in pre- and post-operative periods, but an improvement in time is seen in general health (p = 0.027), and general health compared to one year ago (p < 0.001).

CONCLUSIONS: Endoscopic transsphenoidal surgery has negligible morbidity and does not negatively affect the nasal function in the long term. Endonasal approach and Trans-septal approach are comparable in terms of morbidity outcomes and general QoL, leaving the choice of the approach to the surgeon preference.

Errataetall:

CommentIn: Eur Arch Otorhinolaryngol. 2024 Mar 1;:. - PMID 38429384

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:281

Enthalten in:

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery - 281(2024), 1 vom: 01. Jan., Seite 257-266

Sprache:

Englisch

Beteiligte Personen:

Ferreli, Fabio [VerfasserIn]
Lasagna, Chiara [VerfasserIn]
Canali, Luca [VerfasserIn]
Baram, Ali [VerfasserIn]
Bono, Beatrice C [VerfasserIn]
Tropeano, Maria Pia [VerfasserIn]
Pirola, Francesca [VerfasserIn]
Morenghi, Emanuela [VerfasserIn]
Mercante, Giuseppe [VerfasserIn]
Spriano, Giuseppe [VerfasserIn]
Milani, Davide [VerfasserIn]
Lasio, Giovanni [VerfasserIn]
Colombo, Giovanni [VerfasserIn]

Links:

Volltext

Themen:

Endoscopic pituitary surgery
Journal Article
Observational Study
Pituitary adenoma
Quality of life
Randomized Controlled Trial
Skull base surgery

Anmerkungen:

Date Completed 04.01.2024

Date Revised 01.03.2024

published: Print-Electronic

CommentIn: Eur Arch Otorhinolaryngol. 2024 Mar 1;:. - PMID 38429384

Citation Status MEDLINE

doi:

10.1007/s00405-023-08216-1

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM361714785